Tradestie Institutional Equity Comparison Engine

ACET vs SHPD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACET Overall Edge

ACET Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adicet Bio, Inc. Common Stock (ACET) driven by superior Valuation, Growth & Margin while SHPD counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, ACET trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus SHPD at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ACET sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against SHPD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ACET
ACET N/M vs SHPD N/M Fwd P/E
Growth & Margin Winner ACET
Op Margin 0.0% vs N/A ยท YoY -100.0% vs N/A
Momentum & Technical Winner SHPD
1Y +314.7% vs +20.6% ยท 52W Pos 24% vs 78%
Options & Structure Winner SHPD
BREAKDOWN (6th %ile IV) vs UNCLASSIFIED (N/A IV)
ACET NASDAQ
Adicet Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.75
-1.08% 1D
Market Cap $26.0M
1M Return -39.82%
1Y Return +314.72%
Forward P/E N/M
Unified AI Score
46.7 / 100 HOLD
Tech 45.0 Fund 48.0 Flow 67.0 Mom 40.0
SHPD NASDAQ
Direxion Daily SHOP Bear 1X ETF
Institutional Equity
$23.55
+1.31% 1D
Market Cap N/A
1M Return +14.43%
1Y Return +20.58%
Forward P/E N/M
Unified AI Score
60.0 / 100 BUY
Tech 75.0 Fund 62.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACET +314.72% SHPD +20.58% Spread: +900.99 pp (ACET Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACET TTM Op. Margin: 0.0% SHPD TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACET vs SHPD. Trailing 12-month operating profitability (ACET 0.0% vs SHPD N/A) and valuation multiples (ACET N/M vs SHPD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACET (6) vs SHPD (2)
Institutional Metric ACET SHPD Criterion Row Winner
Market Capitalization Scale $26.0M N/A Larger Scale ACET
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% N/A Higher Growth ACET
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin ACET
Net Profit Margin Profitability 0.0% N/A Higher Margin ACET
Return on Equity (ROE) Capital Efficiency -85.9% N/A Higher ROE ACET
52-Week Range Position Momentum 24% ($0โ€“$10) 78% ($16โ€“$26) Stronger Trend SHPD
Beta / 30D Volatility Risk Regime 1.90ฮฒ ยท 45% Vol -2.40ฮฒ ยท 48% Vol Lower Realized Risk ACET
Unified Institutional Score Composite Signal 46.7 / 100 (HOLD) 60.0 / 100 (BUY) Higher Composite SHPD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACET vs SHPD Buy Guide
ACET BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ACET Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SHPD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SHPD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACET nor SHPD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.